Interested? Contact us now
In order to contact us please fill the form on the right or directly email us at the address below
sales@senecaesg.comStellantis [STLA:US], the parent company of renowned vehicle brands such as Chrysler and Maserati, has disclosed a significant investment of USD1.6bn in Chinese electric vehicle (EV) manufacturer Leapmotor, as reported by Reuters on October 26. This investment secures Stellantis a 21% equity stake in Leapmotor, along with two seats on Leapmotor’s board. Leapmotor, ranking ninth in new energy vehicle (NEV) sales in China, has emerged as a key player in the Chinese EV market. As part of this collaboration, the two companies will establish the Leapmotor International joint venture (JV) with a focus on introducing Leapmotor products beyond Greater China starting in the latter half of 2024. This strategic alliance empowers Stellantis to leverage Leapmotor’s advanced technology and robust manufacturing capabilities, enhancing the European automaker’s presence and sales in the dynamic Chinese market.
In response to the global shift toward electric vehicles, Stellantis, like other established automakers, is adapting its strategies to align with this transformation. With many Chinese EV manufacturers launching competitively priced models in Europe, Stellantis aims to capitalize on this trend through its partnership with Leapmotor. Notably, this collaboration not only benefits Stellantis but also elevates the brand value of Leapmotor, which faced a net loss of RMB5.1bn (USD734m) in 2022 amid the intense price competition in China’s automobile market. This move mirrors a broader trend within the automotive industry, as demonstrated by Volkswagen [VOW:GR], which recently announced a substantial investment of USD700m in Chinese EV manufacturer Xpeng [9868:HK].
Sources:
https://www.ft.com/content/e9071987-4931-4a4f-bcc7-a975a285ecf9
Volkswagen takes 5% stake in XPeng as part of Chinese EV deal
Monitor ESG performance in portfolios, create your own ESG frameworks, and make better informed business decisions.
In order to contact us please fill the form on the right or directly email us at the address below
sales@senecaesg.com7 Straits View, Marina One East Tower, #05-01, Singapore 018936
+65 6223 8888
Gustav Mahlerplein 2 Amsterdam, Netherlands 1082 MA
(+31) 6 4817 3634
77 Dunhua South Road, 7F Section 2, Da'an District Taipei City, Taiwan 106414
(+886) 02 2706 2108
Viet Tower 1, Thai Ha, Dong Da Hanoi, Vietnam 100000
(+84) 936 075 490
Av. Santo Toribio 143,
San Isidro, Lima, Peru, 15073
(+51) 951 722 377
1-4-20 Nishikicho, Tachikawa City, Tokyo 190-0022